This issue, learn all about Oncode Investigator Peter ten Dijke’s work on the TGF-β growth factor, with the ultimate goal of developing novel cancer treatments (Story section). Read further for insights into the challenges of turning a drug target or a biomarker into a clinical product, in the Dialogue between Oncode Investigator Rebekka Schneider and Jan Groen, CEO of Intravacc and member of the Investment Advisory Committee of the Oncode Bridge Fund. And don’t forget the #Eureka section for the latest updates, and the Portrait section - for your chance to get to know Oncode Investigator Anne Rios better.

Click here to open the magazine